Longeveron Inc-a (LGVN) — Institutional Investor Activity (Q2 2026)

Biotech company Longeveron Inc. (LGVN) is executing a one-for-ten reverse stock split, combining every ten shares of its Class A and Class B common stock into a single share. Shareholders signed off on the idea at the July 1, 2026 annual meeting (within an authorized range of 1-for-2 up to 1-for-20), the board locked in 1-for-10 on July 31, and the company filed the amendment in Delaware on August 20. The split takes effect at 11:59 p.m. ET on August 26, and the stock begins trading on a split-adjusted basis under its usual ticker 'LGVN' with a new CUSIP number on August 27 — no fractional shares will be issued, and positions held through brokers adjust automatically.

AI summary pending

AI summary pending

Longeveron Inc. disclosed in an 8-K filing that it temporarily fell out of compliance with Nasdaq Listing Rule 5605(c)(2)(A) following a director's resignation in March, which left its audit committee without enough independent members and a financial expert. The company held its annual meeting in July and elected three new board members. On July 24, the board reconstituted the audit committee with four independent directors, including one audit committee financial expert, resolving the issue.

Longeveron revised its CEO Stephen Willard's employment agreement on July 8, 2026. The new agreement removes the previous salary deferral, making his $500,000 base salary payable immediately. It also sets his bonus target at 45% of salary, with 80% based on company goals and 20% at board discretion. Additionally, his initial equity awards (200,000 restricted stock units and 200,000 stock options) will now vest quarterly over three years instead of four.

Longeveron Inc. filed an 8-K on July 8, 2026, reporting that on July 6 it granted special equity awards to the Executive Chairman. The awards include 500,000 restricted stock units (RSUs) tied to his role in closing a March 2026 financing deal, plus an additional 100,000 RSUs and 400,000 non-qualified stock options for his continued service. These awards vest quarterly over three years, starting October 1, 2026.

Longeveron (LGVN) announced that CFO Lisa Locklear will step down on July 10, 2026, and appointed Marie Washburn as the new CFO, effective July 13, 2026. Washburn, who previously served as Vice President and Corporate Controller, will receive a base salary of $340,000 and an equity award of 130,000 restricted stock units. The company also appointed Dr. Arjun Desai to its board of directors.